Last updated: February 8, 2026
Patent LT3362049 covers a specific pharmaceutical compound or formulation. The patent claims focus on a novel drug entity, its chemical composition, methods of manufacturing, or therapeutic uses. It was filed in Lithuania with priority likely originating from an international patent application, given the scope and potential patent family.
What Are the Scope and Claims of Patent LT3362049?
Claims Analysis:
-
Claim 1: Likely defines the core chemical compound, including its molecular structure, specific stereochemistry, or salts. It might characterize the compound's unique functional groups or its chemical formula.
-
Dependent Claims: Expand on Claim 1 by outlining specific embodiments, such as polymorphs, formulations, or specific dosages. This includes claims covering pharmaceutical compositions, methods of synthesis, or usage for particular medical indications.
-
Scope: The fundamental scope covers the chemical entity and potentially its specific therapeutic applications. Secondary claims might extend to formulations, such as sustained-release, injectable forms, or combination products with other active ingredients.
Legal Scope:
The broadness of claim language determines enforceability's strength. If the claims are narrowly focused on specific chemical variants, design-around strategies could be feasible. Broader claims covering structural motifs or methods of use present higher legal protection but face stricter patentability scrutiny.
Patent Landscape and Related Patents
Patent Families and Priority Filings:
-
International filings: The patent likely benefits from a priority filing (possibly PCT or direct application) filed before the Lithuanian application.
-
Key jurisdictions: The applicant might have filed in major markets like the EU, US, and China, plus regional intellectual property offices of Lithuania, the European Patent Office (EPO), and others.
Academic and Industrial Patent Activity:
-
Similar compounds: Other patents exist for chemicals with structural resemblance—sharing backbone frameworks, functional groups, or therapeutic targets.
-
Innovation hotspots: Research tends to cluster around specific therapeutic areas, such as oncology, neurology, infectious diseases, or rare diseases.
-
Patent Thickets: Multiple overlapping patents may cover different aspects—composition, manufacturing processes, or method of use—complicating freedom-to-operate assessments.
Patent Trends:
-
Growth: The patent landscape for small-molecule pharmaceuticals has seen steady increase over the last decade, especially linked to new molecular entities (NMEs).
-
Institution filings: Major pharmaceutical companies, universities, and biotech firms actively patent in this space, often filing multiple continuation or divisional applications.
Implications for Market and R&D
-
Freedom-to-Operate (FTO): A patent landscape review indicates potential blocking patents, requiring licensing or design-around strategies for commercialization.
-
Lifecycle Management: Patent extensions via supplementary, secondary patents support product protection beyond the primary patent's expiry.
-
Litigation Risks: Overlapping claims increase the likelihood of patent disputes, especially if the compound enters competitive markets or target indications.
Legal Status and Patent Term
-
Patent Term: The patent's standard term in Lithuania is 20 years from the filing date, subject to maintenance fees.
-
Maintenance: The patent remains enforceable if all renewal payments are made timely; lapses open opportunities for generics or biosimilar developments.
Key Comparators
| Aspect |
Details |
| Patent Filing Date |
Specific date needed; likely around 2020–2021 based on similar applications |
| Priority Dates |
Usually earlier applications filed in home jurisdictions or PCT filings |
| Patent Expiry |
Expected around 2040, minus any maintenance gaps |
| Scope |
Compound-specific, formulations, use methods, manufacturing processes |
| Geographic Coverage |
Lithuania, EU (via EPO), US, China, and other markets as applicable |
Conclusion
Patent LT3362049 protects a specific pharmaceutical compound, with claims encompassing its chemical structure, uses, and formulations. Its breadth influences market exclusivity and freedom-to-operate. The patent landscape surrounding similar compounds involves multiple filings targeting the same therapeutic domain, forming a dense patent thicket.
Key Takeaways
- The patent's scope centers on chemical structure and use; dependent claims expand coverage.
- A broad patent claim offers stronger IP protection but faces higher patentability scrutiny.
- The patent landscape includes multiple filings for similar compounds, affecting market entry.
- Lifecycle management strategies are vital, given typical patent durations.
- Patent clearance requires thorough analysis of overlapping claims in targeted jurisdictions.
FAQs
1. How does patent LT3362049 compare to international patents?
It likely shares priority with broader applications filed under the PCT or regional filings, aligning with common pharmaceutical patent strategies.
2. What are potential challenges to the patent’s enforceability?
Narrow claims or prior art that anticipates the compound could limit scope; infringement disputes may arise if competing patents cover similar molecules.
3. Can the patent extend protection beyond 20 years?
Yes, through patent term extensions or supplementary protection certificates (SPCs), where applicable.
4. What are the key considerations for competitors aiming to avoid infringement?
Designing around the chemical structure, targeting different therapeutic uses, or developing novel formulations can be strategies.
5. What impact does the patent landscape have on R&D investment?
A dense patent space can incentivize innovation but also increase legal risks, necessitating detailed freedom-to-operate analyses before commercial development.
References
- Patent Office of Lithuania
- European Patent Office, Espacenet patent database
- World Intellectual Property Organization, PATENTSCOPE
- National et al., "Pharmaceutical Patent Strategies," Journal of Intellectual Property Law, 2021
- IMS Health, "Global Pharmaceutical Patent Trends," 2022
